Protara Therapeutics, Inc. APIC, Share-based Payment Arrangement, Recognition and Exercise
Protara Therapeutics, Inc. (TARA) reported APIC, Share-based Payment Arrangement, Recognition and Exercise of $108.00 thousand for the 12-month period ending 2017-12-31, per its 10-K filed 2019-03-13.
Discontinued › Notes › Stockholders' Equity Note
us-gaap:AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationAndExerciseOfStockOptions · last filed 2019-03-13
- Protara Therapeutics, Inc. apic, share-based payment arrangement, recognition and exercise for fiscal 2017 was $108.00K, a 45.18% decline from fiscal 2016.
- Protara Therapeutics, Inc. apic, share-based payment arrangement, recognition and exercise for fiscal 2016 was $197.00K, a 123.86% increase from fiscal 2015.
- Protara Therapeutics, Inc. apic, share-based payment arrangement, recognition and exercise for fiscal 2015 was $88.00K, a 49.15% increase from fiscal 2014.
- Protara Therapeutics, Inc. apic, share-based payment arrangement, recognition and exercise for fiscal 2014 was $59.00K, a 210.53% increase from fiscal 2013.
| Period end | APIC, Share-based Payment Arrangement, Recognition and Exercise 12 month |
|---|---|
| 2017-12-31 | $108.00K 10-K · filed 2019-03-13 |
| 2016-12-31 | $197.00K 10-K · filed 2019-03-13 |
| 2015-12-31 | $88.00K 10-K · filed 2018-03-14 |
| 2014-12-31 | $59.00K 10-K · filed 2017-03-16 |
| 2013-12-31 | $19.00K 10-K · filed 2016-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |